Navigation Links
BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Date:7/28/2009

BIRMINGHAM, Ala., July 28 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that its second quarter 2009 financial results will be released on Thursday, July 30, 2009. BioCryst will host a conference call and Web cast at 11:00 a.m. Eastern Time to discuss the financial results and provide an update on the Company's programs. The call will be led by Jon P. Stonehouse, President and Chief Executive Officer, Stuart Grant, Chief Financial Officer and Dr. William P. Sheridan, Chief Medical Officer.

The Web cast can be accessed by logging onto http://www.biocryst.com. Please connect to the Web site at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed. To participate in the conference call, please dial 1-877-627-6566 (United States) or 1-719-325-4922 (International). No passcode is needed for the call. The audio portion of the Web cast will be archived and available for replay for at least 14 days.

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in oncology, infectious and autoimmune diseases. BioCryst has two product candidates in pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to expand its portfolio of next-generation therapeutic candidates with the potential to address the unmet medical needs of patients and physicians. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
2. BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
3. BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
4. BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
5. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
6. BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
7. BioCryst to Present at the JMP Healthcare Focus Conference
8. BioCryst to Present at UBS 2008 Global Life Sciences Conference
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
11. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... , May 22, 2013  Moderna Therapeutics, the pioneering ... modality to enable the in vivo production ... Reynders will join Moderna in early July ... Reynders is a proven leader in the design and ... development, from discovery to translation, clinical operations and commercial ...
(Date:5/21/2013)... 2013 Through science fairs, workshops, kits ... lab equipment, 25 organizations will continue their work to ... and photonics in daily life with the aid of ... located in 10 countries, are the first of two ... SPIE, the international society for optics and photonics ...
Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... PALO ALTO, Calif. , Feb. 1 Telik, Inc. ... corporate overview at the 12th Annual BIO CEO & Investor Conference in ... 3:00 p.m. Eastern time ( 12:00 p.m. Pacific time ). ... the Telik website, www.telik.com . , Telik, Inc. of Palo ...
... , LEWISTON, Maine , Feb. ... presented by Amgen is officially open and are accepted through ... event serves as the primary fundraiser for The Patrick Dempsey ... Center, in Lewiston, ME , which provides free support, ...
... FORT LAUDERDALE, Fla. , Feb. 1 ... (EuroIntervention, 2010; 5:698-702) demonstrated good safety and efficacy, ... thrombosis at one year in patients with ST-elevation myocardial ... and implantation of the company,s Genous Bio-engineered R stent. ...
Cached Biology Technology:Dempsey Challenge Participant Registration Officially Open 2Dempsey Challenge Participant Registration Officially Open 3Dempsey Challenge Participant Registration Officially Open 4OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI 2OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI 3
(Date:5/21/2013)... genes function without changing the underlying DNA sequence, ... pregnant women during any trimester, potentially providing a ... after giving birth, and an opportunity to intervene ... the small study involving 52 pregnant women are ... . , "Postpartum depression can be harmful to ...
(Date:5/20/2013)... the effect of physical education (PE) on child weight, ... increasing the amount of time that elementary schoolchildren spent ... The study represents some of the first evidence of ... is forthcoming in the Journal of Health Economics ... can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The ...
(Date:5/20/2013)... grant will help establish the Center for Advanced Research ... of Illinois at Urbana-Champaign and Worcester Polytechnic Institute (WPI) ... research in drying moist, porous materials such as food ... products; textiles; and biopharmaceuticals," said Hao Feng, a U ... and the Illinois site director. , According to Feng, ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Gym class reduces probability of obesity, study finds for first time 2NSF approves planning grant for Center for Advanced Research in Drying 2
... . , New research explains how cells regulate their ... time, the role of the protein Raf-1 in determining the strength ... at the Max F. Perutz Laboratories, a joint venture of the ... Raf-1 is not present, the cells cannot stick together and the ...
... Two-timing is nothing out of the ordinary for them: ... breeding in a three-gender system. This was discovered by Dr. ... Geobotany Laboratory in cooperation with colleagues from the Heinrich Heine ... structure of the responsible regions in the genome has hardly ...
... Nitrogen is both an essential nutrient and a ... fertilizer that feeds billions, a benefit and a hazard, ... transportation have spread nitrogen liberally around the planet, say ... Issues in Ecology series, "Excess Nitrogen in the ...
Cached Biology News:Essential protein for the formation of new blood vessels identified 22-timing and hybrids: RUB researchers look back on 100 million years of evolution 2Solutions for a nitrogen-soaked world 2
Applications: (+) Immunocytochemistry and immunohistochemistry...
For the quantitative determination of canine Interferon gamma,(IFN-γ) concentrations in cell culture supernates, serum and,plasma....
Non-Protein Peroxidase Stabilizer , 1 L...
... Rabbit Reticulocyte Lysate contains the cellular components ... acids, initiation, elongation and termination factors) but ... Untreated Lysate is used primarily for the ... abundant source of endogenous globin mRNA. Untreated ...
Biology Products: